These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10504169)

  • 61. [Advances in tumor surgery. II].
    Linder F
    Verh Dtsch Ges Inn Med; 1972; 78():72-82. PubMed ID: 4665743
    [No Abstract]   [Full Text] [Related]  

  • 62. Tumor localization for breast cancer patients receiving neoadjuvant chemotherapy.
    Wu ZY; Kim N; Ko B
    Breast Cancer Res Treat; 2021 Jan; 185(2):531-532. PubMed ID: 33057994
    [No Abstract]   [Full Text] [Related]  

  • 63. Surgical implications of multigenic testing during neoadjuvant chemotherapy treatment in high-risk women with breast cancer.
    Sánchez Escudero L; Rodríguez Garcés MY; Jiménez Ruiz FJ
    Cir Esp (Engl Ed); 2023 Mar; 101(3):224-226. PubMed ID: 36152964
    [No Abstract]   [Full Text] [Related]  

  • 64. Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.
    Marron TU; Galsky MD; Taouli B; Fiel MI; Ward S; Kim E; Yankelevitz D; Doroshow D; Guttman-Yassky E; Ungar B; Mehandru S; Golas BJ; Labow D; Sfakianos J; Nair SS; Chakravarty D; Buckstein M; Song X; Kenigsberg E; Gnjatic S; Brown BD; Sparano J; Tewari A; Schwartz M; Bhardwaj N; Merad M
    Nat Med; 2022 Apr; 28(4):626-629. PubMed ID: 35347282
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Randomized adjuvant trials in oncology: a necessity or time-consuming luxury?
    Ragaz J
    Breast Cancer Res; 2010 Dec; 12 Suppl 4(Suppl 4):S14. PubMed ID: 21172076
    [No Abstract]   [Full Text] [Related]  

  • 66. CORR Insights®: Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
    Miller BJ
    Clin Orthop Relat Res; 2018 Nov; 476(11):2187-2189. PubMed ID: 30188347
    [No Abstract]   [Full Text] [Related]  

  • 67. Neoadjuvant chemotherapy prior to radical operation as a risk factor for nocturnal oxygen desaturation in perioperative periods.
    Ishikawa T; Isono S; Nehashi S; Nishino T
    Masui; 2002 Apr; 51(4):408-10. PubMed ID: 11995350
    [No Abstract]   [Full Text] [Related]  

  • 68. [Neo-adjuvant chemotherapy: a correct concept, an ambiguous term and multiple applications].
    Jacquillat C; Weil M; Khayat D
    Nouv Rev Fr Hematol (1978); 1986; 28(1):1-2. PubMed ID: 3714463
    [No Abstract]   [Full Text] [Related]  

  • 69. Cancer surgery: a commentary.
    Fisher B
    Cancer Treat Rep; 1984 Jan; 68(1):31-41. PubMed ID: 6692431
    [No Abstract]   [Full Text] [Related]  

  • 70. Cancer chemotherapy aimed at potential cell regulators.
    Knock FE; Galt RM; Oester YT; Renaud OV; Sylvester R
    JAMA; 1969 Apr; 208(3):534-5. PubMed ID: 5818536
    [No Abstract]   [Full Text] [Related]  

  • 71. Preoperative (neoadjuvant) chemotherapy.
    Recent Results Cancer Res; 1986; 103():1-162. PubMed ID: 3738191
    [No Abstract]   [Full Text] [Related]  

  • 72. [Interdisciplinary--clinical trials in patients with cancer].
    Wagener DJ
    TVZ; 1989 Jul; 43(14):463-5. PubMed ID: 2503011
    [No Abstract]   [Full Text] [Related]  

  • 73. [Clinically controlled research in tumor chemotherapy].
    Nissen NI
    Nord Med; 1971 Apr; 85(16):502. PubMed ID: 4929821
    [No Abstract]   [Full Text] [Related]  

  • 74. Systemic chemotherapy for primary breast cancer.
    Br Med J; 1977 Feb; 1(6060):576. PubMed ID: 321070
    [No Abstract]   [Full Text] [Related]  

  • 75. Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective.
    Pavic M; Wolfer A; Li Q; Gircys A; Juritz S; Wicki A; Cerny T; Rohr UP
    J Clin Oncol; 2023 Nov; 41(32):4973-4975. PubMed ID: 37733978
    [No Abstract]   [Full Text] [Related]  

  • 76. Biomarkers in neoadjuvant trials.
    Fearmonti RM; Keyomarsi K; Hunt KK
    Cancer Treat Res; 2009; 147():1-36. PubMed ID: 21461824
    [No Abstract]   [Full Text] [Related]  

  • 77. [Strategies for preoperative therapy of locoregional cancers: an opportunity for expanding current concepts].
    Ajani JA
    Chirurg; 2000 Dec; 71(12):1431-2. PubMed ID: 11195060
    [No Abstract]   [Full Text] [Related]  

  • 78. SSO 2020 virtual meeting.
    Lai C
    Lancet Oncol; 2020 Oct; 21(10):1263. PubMed ID: 32861272
    [No Abstract]   [Full Text] [Related]  

  • 79. ASO Author Reflections: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients.
    Newhook TE; Tzeng CD
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):749-750. PubMed ID: 31559543
    [No Abstract]   [Full Text] [Related]  

  • 80. Chemotherapy Only For High-risk Features.
    Yang GY; Caudell JJ
    Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):13. PubMed ID: 35964626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.